Jag Chhatwal on Twitter: "After #HepC cure, which patients--and until what age--should undergo screening for HCC? Our study in @JHepatology (@EASLnews) shows biannual screening is cost-effective until the age of 70 for
![Hepatitis C Cure, Sofosbuvir, Turns 5 Years Old: The Vast Majority of People Still Nave Not Been Treated Hepatitis C Cure, Sofosbuvir, Turns 5 Years Old: The Vast Majority of People Still Nave Not Been Treated](https://hepcoalition.org/IMG/png/en_treatment-uptake-sovaldivs-generic.png)
Hepatitis C Cure, Sofosbuvir, Turns 5 Years Old: The Vast Majority of People Still Nave Not Been Treated
![Assessment of the cost-effectiveness of Australia's risk-sharing agreement for direct-acting antiviral treatments for hepatitis C: a modelling study - The Lancet Regional Health – Western Pacific Assessment of the cost-effectiveness of Australia's risk-sharing agreement for direct-acting antiviral treatments for hepatitis C: a modelling study - The Lancet Regional Health – Western Pacific](https://www.thelancet.com/cms/attachment/5b1f7295-4ded-4b33-9abf-5e9d2a390ed6/gr1_lrg.jpg)
Assessment of the cost-effectiveness of Australia's risk-sharing agreement for direct-acting antiviral treatments for hepatitis C: a modelling study - The Lancet Regional Health – Western Pacific
![Hepatitis C elimination in Myanmar: Modelling the impact, cost, cost-effectiveness and economic benefits - The Lancet Regional Health – Western Pacific Hepatitis C elimination in Myanmar: Modelling the impact, cost, cost-effectiveness and economic benefits - The Lancet Regional Health – Western Pacific](https://www.thelancet.com/cms/attachment/8840effc-b509-4165-ae7e-c5e08090b170/gr1_lrg.jpg)
Hepatitis C elimination in Myanmar: Modelling the impact, cost, cost-effectiveness and economic benefits - The Lancet Regional Health – Western Pacific
![Treating Hepatitis C in a Substance Use Recovery Program: A Limited-Resource Group Model | NEJM Catalyst Treating Hepatitis C in a Substance Use Recovery Program: A Limited-Resource Group Model | NEJM Catalyst](https://catalyst.nejm.org/cms/asset/1b103eed-91c4-448b-a4c3-761fb3cfecaf/cat.21.0453-f1.jpg)
Treating Hepatitis C in a Substance Use Recovery Program: A Limited-Resource Group Model | NEJM Catalyst
![New Medi-Cal rules ease access to hepatitis C drugs | LAist - NPR News for Southern California - 89.3 FM New Medi-Cal rules ease access to hepatitis C drugs | LAist - NPR News for Southern California - 89.3 FM](https://scpr.brightspotcdn.com/dims4/default/11752b8/2147483647/strip/true/crop/453x238+285+0/resize/1200x630!/quality/90/?url=https%3A%2F%2Fa.scpr.org%2F129093_4fb80015cdeb193e7f4eea2cf162ef76_original.png)